Your browser doesn't support javascript.
Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide.
Barquera, Rodrigo; Collen, Evelyn; Di, Da; Buhler, Stéphane; Teixeira, João; Llamas, Bastien; Nunes, José M; Sanchez-Mazas, Alicia.
  • Barquera R; Department of Archaeogenetics, Max Planck Institute for the Science of Human History, Jena, Germany.
  • Collen E; Australian Centre for Ancient DNA (ACAD), Department of Genetics and Evolution, The University of Adelaide, Adelaide, South Australia, Australia.
  • Di D; Anthropology Unit, Department of Genetics and Evolution, University of Geneva, Geneva, Switzerland.
  • Buhler S; Anthropology Unit, Department of Genetics and Evolution, University of Geneva, Geneva, Switzerland.
  • Teixeira J; Transplantation Immunology Unit and National Reference Laboratory for Histocompatibility, Department of Diagnostic, Geneva University Hospitals, Geneva, Switzerland.
  • Llamas B; Australian Centre for Ancient DNA (ACAD), Department of Genetics and Evolution, The University of Adelaide, Adelaide, South Australia, Australia.
  • Nunes JM; School of Biological Sciences, Centre of Excellence for Australian Biodiversity and Heritage, The University of Adelaide, Adelaide, South Australia, Australia.
  • Sanchez-Mazas A; School of Biological Sciences, Centre of Excellence for Australian Biodiversity and Heritage, The University of Adelaide, Adelaide, South Australia, Australia.
HLA ; 96(3): 277-298, 2020 09.
Article in English | MEDLINE | ID: covidwho-1388402
ABSTRACT
We report detailed peptide-binding affinities between 438 HLA Class I and Class II proteins and complete proteomes of seven pandemic human viruses, including coronaviruses, influenza viruses and HIV-1. We contrast these affinities with HLA allele frequencies across hundreds of human populations worldwide. Statistical modelling shows that peptide-binding affinities classified into four distinct categories depend on the HLA locus but that the type of virus is only a weak predictor, except in the case of HIV-1. Among the strong HLA binders (IC50 ≤ 50), we uncovered 16 alleles (the top ones being A*0202, B*1503 and DRB1*0102) binding more than 1% of peptides derived from all viruses, 9 (top ones including HLA-A*6801, B*1525, C*0302 and DRB1*0701) binding all viruses except HIV-1, and 15 (top ones A*0201 and C*1402) only binding coronaviruses. The frequencies of strongest and weakest HLA peptide binders differ significantly among populations from different geographic regions. In particular, Indigenous peoples of America show both higher frequencies of strongest and lower frequencies of weakest HLA binders. As many HLA proteins are found to be strong binders of peptides derived from distinct viral families, and are hence promiscuous (or generalist), we discuss this result in relation to possible signatures of natural selection on HLA promiscuous alleles due to past pathogenic infections. Our findings are highly relevant for both evolutionary genetics and the development of vaccine therapies. However they should not lead to forget that individual resistance and vulnerability to diseases go beyond the sole HLA allelic affinity and depend on multiple, complex and often unknown biological, environmental and other variables.
Subject(s)
Coronavirus Infections/epidemiology; HIV Infections/epidemiology; HLA Antigens/chemistry; Influenza, Human/epidemiology; Pandemics; Peptides/chemistry; Pneumonia, Viral/epidemiology; Severe Acute Respiratory Syndrome/epidemiology; Viral Proteins/chemistry; Africa/epidemiology; Americas/epidemiology; Amino Acid Sequence; Asia/epidemiology; Australia/epidemiology; Betacoronavirus/genetics; Betacoronavirus/immunology; COVID-19; Computational Biology; Coronavirus Infections/immunology; Coronavirus Infections/virology; Europe/epidemiology; HIV Infections/immunology; HIV Infections/virology; HIV-1/genetics; HIV-1/immunology; HLA Antigens/classification; HLA Antigens/genetics; HLA Antigens/immunology; Humans; Influenza A Virus, H1N1 Subtype/genetics; Influenza A Virus, H1N1 Subtype/immunology; Influenza A Virus, H3N2 Subtype/genetics; Influenza A Virus, H3N2 Subtype/immunology; Influenza A Virus, H7N9 Subtype/genetics; Influenza A Virus, H7N9 Subtype/immunology; Influenza, Human/immunology; Influenza, Human/virology; Kinetics; Middle East Respiratory Syndrome Coronavirus/genetics; Middle East Respiratory Syndrome Coronavirus/immunology; Peptides/genetics; Peptides/immunology; Pneumonia, Viral/immunology; Pneumonia, Viral/virology; Protein Binding; Severe acute respiratory syndrome-related coronavirus/genetics; Severe acute respiratory syndrome-related coronavirus/immunology; SARS-CoV-2; Severe Acute Respiratory Syndrome/immunology; Severe Acute Respiratory Syndrome/virology; Viral Proteins/genetics; Viral Proteins/immunology
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Peptides / Pneumonia, Viral / Viral Proteins / HIV Infections / Coronavirus Infections / Severe Acute Respiratory Syndrome / Influenza, Human / Pandemics / HLA Antigens Type of study: Observational study / Prognostic study Topics: Vaccines Country/Region as subject: Africa / Asia / Europa / Oceania Language: English Journal: HLA Year: 2020 Document Type: Article Affiliation country: TAN.13956

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Peptides / Pneumonia, Viral / Viral Proteins / HIV Infections / Coronavirus Infections / Severe Acute Respiratory Syndrome / Influenza, Human / Pandemics / HLA Antigens Type of study: Observational study / Prognostic study Topics: Vaccines Country/Region as subject: Africa / Asia / Europa / Oceania Language: English Journal: HLA Year: 2020 Document Type: Article Affiliation country: TAN.13956